China Bio-Immunity Recovers Most of Recalled Rabies Vaccine

The China operating subsidiary of China Bio-Immunity Corporation has recovered most of the rabies vaccine that was found to have a flaw. Last year, Dalian Jingang-Andi Bio-products Co. (JGAD) of Dalian City Liaoning Province produced 360,200 doses of the vaccine. 321,800 have been recovered as part of a recall operation. The problem with the vaccine seems to be in the nucleic acid materials that were used as an adjuvant to the vaccine, which were called an “illegal ingredient.” More details...

Stock Symbol: (OTCBB: CHHB)